Life Science Opportunities Fund VI Puissance serves as Executive at Tracon Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Life Science Opportunities Fund VI Puissance has executed 4 insider transactions totaling $117.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 13, 2023 involved selling 1,076,841 shares valued at $107.7K.
Life Science Opportunities Fund VI Puissance currently holds 1,763,077 shares of Tracon Pharmaceuticals, Inc. (TCON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Life Science Opportunities Fund VI Puissance has been a net seller of TCON stock. They have purchased $4.9K and sold $112.9K worth of shares.
Life Science Opportunities Fund VI Puissance's most recent insider trade was on Oct 13, 2023, when they sold 1,076,841 shares at $0.10 per share.
Get notified when new Form 4 filings are submitted
| $4.00 |
| Discretionary |
| Nov 29, 2018 | TCON | $4.9K | Purchase | 4,326 | $1.13 | Discretionary |
| Nov 29, 2018 | TCON | $5.2K | Sale | 4,326 | $1.21 | Discretionary |